Status: Recruiting
Phase IIa Trial in Participants With Asthma to Evaluate Impact of Intranasal ETH47 on Development of Asthma-related Symptoms Following Rhinovirus Challenge
A Phase IIa trial in participants with asthma to evaluate the impact of intranasal ETH47 on the development of asthma-related symptoms following rhinovirus challenge
Participants needed: 50
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Ethris GmbHUpdated: Jun 26, 2026Locations: 2
Eligibility criteria
Capable of giving signed informed consent which includes compliance with the req... [+6]
Any cold symptom within the last month such as sore throat, sneezing, rhinorrhoe... [+4]